Dr. Yasser A. Khaled

Jennifer Tseng, MD, hematologist/medical oncologist, is the Thoracic/Head and Neck Specialty Section leader for Medical Oncology and the associate director of Clinical Research for Medical Oncology at Orlando Health Cancer Institute.Dr. Tseng received her medical degree from Duke University School of Medicine. She completed her residency and served as assistant chief resident in internal medicine at Duke University Medical Center. She completed a fellowship in medical oncology and hematology at The University of Texas MD Anderson Cancer Center in Houston. She is board-certified in internal medicine and medical oncology and board-eligible in hematology. Dr. Tseng has received several honors and awards, including the C.D. Howe Award for clinical excellence in medical oncology and a Clinical Research Award from MD Anderson, the American Medical Women's Award, Hewlett Packard Award, the Alpha Omega Alpha Research Symposium Award from Duke University and a Beneficial-Hodgson scholarship from The Johns Hopkins University. She was also awarded Attending of the Year from the Internal Medicine Residency Program from Orlando Regional Medical Center and received the Exemplary Physician Colleague Award from Orlando Health in 2009.In addition to her clinical studies, Dr. Tseng has published research on various topics including molecular alterations in lung cancer and novel agents in the treatment of head and neck cancer. She has recently presented at the Annual Thoracic Oncology Symposium of the Puerto Rican Society of Hematology Oncology and spoke on neoadjuvant and adjuvant treatment strategies in lung cancer. Dr. Tseng is highly rated in 29 conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, Lung Adenocarcinoma, and Bone Marrow Aspiration. Dr. Tseng is board certified in American Board Of Internal Med. - Medical Oncology and American Board Of Internal Medicine.

Dr. Juan Carlos Varela is a board-certified and fellowship-trained physician specializing in hematology and oncology with the Bone Marrow Transplant and Cellular Therapy program at the Orlando Health Cancer Institute. He previously served as medical director of a Blood and Marrow Transplant/Cellular Therapy program in Orlando and most recently was medical director for Outpatient Services and led the Acute Leukemia and Bone Marrow Transplant Program in the Division of Hematological Malignancies in Boston. His services include: Bone marrow transplants (autologous, allogeneic, cord blood and haploidentical) Bispecific antibodies CAR-T cell therapy Acute leukemia myelodysplastic syndrome treatment Cellular therapy lab (on-site collection facility and cell manipulation) Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma, graft versus host disease and lung transplant rejection Clinical trials Dr. Varela takes his patients' specific goals and needs into account in order to treat each patient as an individual, rather than taking a blanket approach to treating the disease. Dr. Varela's Training Dr. Varela earned his medical degree and doctorate from the Medical University of South Carolina in Charleston. He completed an internal medicine residency and hematology fellowship at The Johns Hopkins Hospital in Baltimore. About Dr. Varela Dr. Varela is certified in hematology and internal medicine with the American Board of Internal Medicine. He is a member of the American Society for Transplantation and Cellular Therapy and American Society of Hematology. Dr. Varela is a physician scientist and has been the principal investigator in dozens of clinical trials for cellular therapy, hematologic malignancies and bone marrow transplants. He has successfully translated novel immunotherapeutic approaches from the bench to the bedside and has been the leader in multiple first-in-human studies of novel T-cell therapies in hematologic malignancies. His research has been published extensively in peer-reviewed publications on topics including hematopoietic stem cell transplantation, acute myelogenous leukemia and adoptive T cell immunotherapy. Outside of work, Dr. Varela enjoys music, sports and spending time with his family. He is fluent in English and Spanish. Dr. Varela is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Varela is board certified in American Board Of Internal Medicine - Hematology and American Board Of Internal Medicine - Internal Medicine.

Dr. Tirrell Johnson is a board-certified medical oncologist at the Orlando Health Cancer Institute. His specialties include: Head and neck cancers Thoracic cancers Melanoma Sarcoma He is a member of the team pioneering a breakthrough protocol using tumor-infiltrating lymphocytes to address aggressive, late-stage melanoma. Dr. Johnson's Training Dr. Johnson earned a bachelor's degree in chemical engineering from Florida A&M University in Tallahassee, graduating magna cum laude, and received his medical degree from the University of Florida in Gainesville. He completed an internal medicine residency at Orlando Health Orlando Regional Medical Center and a fellowship in hematology and oncology at Brown University Medical School's teaching hospitals in Providence, Rhode Island. About Dr. Johnson Dr. Johnson is board certified in internal medicine and medical oncology by the American Board of Internal Medicine. His professional memberships include the American College of Physicians, American Society of Clinical Oncology and American Society of Hematology. Dr. Johnson received an Orlando Health award for outstanding multidisciplinary involvement with staff. He has served as the primary investigator for clinical trials studying several forms of chemotherapy for advanced head and neck cancers and thoracic malignancies. Dr. Johnson is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and EGFR Positive Lung Cancer. Dr. Johnson is board certified in American Board Of Internal Med. - Medical Oncology and American Board Of Internal Medicine.